Periprocedural pericardial effusion with tamponade (PET) in patients undergoing transcatheter aortic valve replacement (TAVR) can significantly increase morbidity, length of stay, and cost of hospitalization and can be due to… Click to show full abstract
Periprocedural pericardial effusion with tamponade (PET) in patients undergoing transcatheter aortic valve replacement (TAVR) can significantly increase morbidity, length of stay, and cost of hospitalization and can be due to aortic annular rupture or ventricular perforation. Although predictors of
               
Click one of the above tabs to view related content.